img

Global Human Coagulation Factor Ⅷ Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Coagulation Factor Ⅷ Market Insights, Forecast to 2034

Human Coagulation Factor Ⅷ is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene result in hemophilia A, an X-linked coagulation disorder Human Coagulation Factor Ⅷ is produced in liver sinusoidal cells and endothelial cells outside the liver throughout the body. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs. In response to injury, coagulation factor VIII is activated and separates from von Willebrand factor. The active protein (sometimes written as coagulation factor VIIIa) interacts with another coagulation factor called factor IX. This interaction sets off a chain of additional chemical reactions that form a blood clot.
Market Analysis and InsightsGlobal Human Coagulation Factor Ⅷ Market
Global Human Coagulation Factor Ⅷ market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Human Coagulation Factor Ⅷ industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Human Coagulation Factor Ⅷ market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Coagulation Factor Ⅷ market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Pfizer
Segment by Type
Recombinant Factor VIII
Human Factor VIII

Segment by Application


Hemophilia A
Relvent Bleeding Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Human Coagulation Factor Ⅷ introduction, etc. Human Coagulation Factor Ⅷ Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Human Coagulation Factor Ⅷ
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Coagulation Factor Ⅷ Market Perspective (2018-2029)
2.2 Global Human Coagulation Factor Ⅷ Growth Trends by Region
2.2.1 Human Coagulation Factor Ⅷ Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Coagulation Factor Ⅷ Historic Market Size by Region (2018-2024)
2.2.3 Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2024-2029)
2.3 Human Coagulation Factor Ⅷ Market Dynamics
2.3.1 Human Coagulation Factor Ⅷ Industry Trends
2.3.2 Human Coagulation Factor Ⅷ Market Drivers
2.3.3 Human Coagulation Factor Ⅷ Market Challenges
2.3.4 Human Coagulation Factor Ⅷ Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Coagulation Factor Ⅷ by Players
3.1.1 Global Human Coagulation Factor Ⅷ Revenue by Players (2018-2024)
3.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Players (2018-2024)
3.2 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Coagulation Factor Ⅷ, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Human Coagulation Factor Ⅷ Market Concentration Ratio
3.4.1 Global Human Coagulation Factor Ⅷ Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Coagulation Factor Ⅷ Revenue in 2022
3.5 Global Key Players of Human Coagulation Factor Ⅷ Head office and Area Served
3.6 Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
3.7 Global Key Players of Human Coagulation Factor Ⅷ, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Coagulation Factor Ⅷ Breakdown Data by Type
4.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Type (2018-2024)
4.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2024-2029)
5 Human Coagulation Factor Ⅷ Breakdown Data by Application
5.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Application (2018-2024)
5.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Coagulation Factor Ⅷ Market Size (2018-2029)
6.2 North America Human Coagulation Factor Ⅷ Market Size by Type
6.2.1 North America Human Coagulation Factor Ⅷ Market Size by Type (2018-2024)
6.2.2 North America Human Coagulation Factor Ⅷ Market Size by Type (2024-2029)
6.2.3 North America Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
6.3 North America Human Coagulation Factor Ⅷ Market Size by Application
6.3.1 North America Human Coagulation Factor Ⅷ Market Size by Application (2018-2024)
6.3.2 North America Human Coagulation Factor Ⅷ Market Size by Application (2024-2029)
6.3.3 North America Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
6.4 North America Human Coagulation Factor Ⅷ Market Size by Country
6.4.1 North America Human Coagulation Factor Ⅷ Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Human Coagulation Factor Ⅷ Market Size by Country (2018-2024)
6.4.3 North America Human Coagulation Factor Ⅷ Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Coagulation Factor Ⅷ Market Size (2018-2029)
7.2 Europe Human Coagulation Factor Ⅷ Market Size by Type
7.2.1 Europe Human Coagulation Factor Ⅷ Market Size by Type (2018-2024)
7.2.2 Europe Human Coagulation Factor Ⅷ Market Size by Type (2024-2029)
7.2.3 Europe Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
7.3 Europe Human Coagulation Factor Ⅷ Market Size by Application
7.3.1 Europe Human Coagulation Factor Ⅷ Market Size by Application (2018-2024)
7.3.2 Europe Human Coagulation Factor Ⅷ Market Size by Application (2024-2029)
7.3.3 Europe Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
7.4 Europe Human Coagulation Factor Ⅷ Market Size by Country
7.4.1 Europe Human Coagulation Factor Ⅷ Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Human Coagulation Factor Ⅷ Market Size by Country (2018-2024)
7.4.3 Europe Human Coagulation Factor Ⅷ Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Coagulation Factor Ⅷ Market Size (2018-2029)
8.2 China Human Coagulation Factor Ⅷ Market Size by Type
8.2.1 China Human Coagulation Factor Ⅷ Market Size by Type (2018-2024)
8.2.2 China Human Coagulation Factor Ⅷ Market Size by Type (2024-2029)
8.2.3 China Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
8.3 China Human Coagulation Factor Ⅷ Market Size by Application
8.3.1 China Human Coagulation Factor Ⅷ Market Size by Application (2018-2024)
8.3.2 China Human Coagulation Factor Ⅷ Market Size by Application (2024-2029)
8.3.3 China Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Coagulation Factor Ⅷ Market Size (2018-2029)
9.2 Asia Human Coagulation Factor Ⅷ Market Size by Type
9.2.1 Asia Human Coagulation Factor Ⅷ Market Size by Type (2018-2024)
9.2.2 Asia Human Coagulation Factor Ⅷ Market Size by Type (2024-2029)
9.2.3 Asia Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
9.3 Asia Human Coagulation Factor Ⅷ Market Size by Application
9.3.1 Asia Human Coagulation Factor Ⅷ Market Size by Application (2018-2024)
9.3.2 Asia Human Coagulation Factor Ⅷ Market Size by Application (2024-2029)
9.3.3 Asia Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
9.4 Asia Human Coagulation Factor Ⅷ Market Size by Region
9.4.1 Asia Human Coagulation Factor Ⅷ Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Human Coagulation Factor Ⅷ Market Size by Region (2018-2024)
9.4.3 Asia Human Coagulation Factor Ⅷ Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Coagulation Factor Ⅷ Introduction
11.1.4 Bayer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Details
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Human Coagulation Factor Ⅷ Introduction
11.2.4 CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.2.5 CSL Behring Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Human Coagulation Factor Ⅷ Introduction
11.3.4 Baxter Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.3.5 Baxter Recent Developments
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Human Coagulation Factor Ⅷ Introduction
11.4.4 Grifols Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.4.5 Grifols Recent Developments
11.5 Octapharma
11.5.1 Octapharma Company Details
11.5.2 Octapharma Business Overview
11.5.3 Octapharma Human Coagulation Factor Ⅷ Introduction
11.5.4 Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.5.5 Octapharma Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.6.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.6.5 Pfizer Recent Developments
11.7 Taibang Bio
11.7.1 Taibang Bio Company Details
11.7.2 Taibang Bio Business Overview
11.7.3 Taibang Bio Human Coagulation Factor Ⅷ Introduction
11.7.4 Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.7.5 Taibang Bio Recent Developments
11.8 Shanghai Laishi
11.8.1 Shanghai Laishi Company Details
11.8.2 Shanghai Laishi Business Overview
11.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Introduction
11.8.4 Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.8.5 Shanghai Laishi Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Hualan Bio Business Overview
11.9.3 Hualan Bio Human Coagulation Factor Ⅷ Introduction
11.9.4 Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.9.5 Hualan Bio Recent Developments
11.10 Guangdong Shuanglin
11.10.1 Guangdong Shuanglin Company Details
11.10.2 Guangdong Shuanglin Business Overview
11.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Introduction
11.10.4 Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.10.5 Guangdong Shuanglin Recent Developments
11.11 GreenCross
11.11.1 GreenCross Company Details
11.11.2 GreenCross Business Overview
11.11.3 GreenCross Human Coagulation Factor Ⅷ Introduction
11.11.4 GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.11.5 GreenCross Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.12.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024)
11.12.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Recombinant Factor VIII
Table 3. Key Players of Human Factor VIII
Table 4. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Human Coagulation Factor Ⅷ Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Human Coagulation Factor Ⅷ Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Human Coagulation Factor Ⅷ Market Share by Region (2018-2024)
Table 8. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Human Coagulation Factor Ⅷ Market Share by Region (2024-2029)
Table 10. Human Coagulation Factor Ⅷ Market Trends
Table 11. Human Coagulation Factor Ⅷ Market Drivers
Table 12. Human Coagulation Factor Ⅷ Market Challenges
Table 13. Human Coagulation Factor Ⅷ Market Restraints
Table 14. Global Human Coagulation Factor Ⅷ Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Human Coagulation Factor Ⅷ Revenue Share by Players (2018-2024)
Table 16. Global Top Human Coagulation Factor Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2022)
Table 17. Global Human Coagulation Factor Ⅷ Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Human Coagulation Factor Ⅷ Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Human Coagulation Factor Ⅷ, Headquarters and Area Served
Table 20. Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
Table 21. Global Key Players of Human Coagulation Factor Ⅷ, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2018-2024)
Table 25. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2024-2029)
Table 27. Global Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2018-2024)
Table 29. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2024-2029)
Table 31. North America Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Human Coagulation Factor Ⅷ Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Human Coagulation Factor Ⅷ Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Human Coagulation Factor Ⅷ Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Human Coagulation Factor Ⅷ Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Human Coagulation Factor Ⅷ Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Human Coagulation Factor Ⅷ Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Human Coagulation Factor Ⅷ Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Human Coagulation Factor Ⅷ Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Human Coagulation Factor Ⅷ Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Human Coagulation Factor Ⅷ Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Human Coagulation Factor Ⅷ Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Human Coagulation Factor Ⅷ Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Human Coagulation Factor Ⅷ Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Human Coagulation Factor Ⅷ Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Human Coagulation Factor Ⅷ Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Human Coagulation Factor Ⅷ Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Human Coagulation Factor Ⅷ Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size by Country (2024-2029) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Human Coagulation Factor Ⅷ Product
Table 66. Bayer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 67. Bayer Recent Developments
Table 68. CSL Behring Company Details
Table 69. CSL Behring Business Overview
Table 70. CSL Behring Human Coagulation Factor Ⅷ Product
Table 71. CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 72. CSL Behring Recent Developments
Table 73. Baxter Company Details
Table 74. Baxter Business Overview
Table 75. Baxter Human Coagulation Factor Ⅷ Product
Table 76. Baxter Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 77. Baxter Recent Developments
Table 78. Grifols Company Details
Table 79. Grifols Business Overview
Table 80. Grifols Human Coagulation Factor Ⅷ Product
Table 81. Grifols Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 82. Grifols Recent Developments
Table 83. Octapharma Company Details
Table 84. Octapharma Business Overview
Table 85. Octapharma Human Coagulation Factor Ⅷ Product
Table 86. Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 87. Octapharma Recent Developments
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Human Coagulation Factor Ⅷ Product
Table 91. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 92. Pfizer Recent Developments
Table 93. Taibang Bio Company Details
Table 94. Taibang Bio Business Overview
Table 95. Taibang Bio Human Coagulation Factor Ⅷ Product
Table 96. Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 97. Taibang Bio Recent Developments
Table 98. Shanghai Laishi Company Details
Table 99. Shanghai Laishi Business Overview
Table 100. Shanghai Laishi Human Coagulation Factor Ⅷ Product
Table 101. Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 102. Shanghai Laishi Recent Developments
Table 103. Hualan Bio Company Details
Table 104. Hualan Bio Business Overview
Table 105. Hualan Bio Human Coagulation Factor Ⅷ Product
Table 106. Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 107. Hualan Bio Recent Developments
Table 108. Guangdong Shuanglin Company Details
Table 109. Guangdong Shuanglin Business Overview
Table 110. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product
Table 111. Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 112. Guangdong Shuanglin Recent Developments
Table 113. GreenCross Company Details
Table 114. GreenCross Business Overview
Table 115. GreenCross Human Coagulation Factor Ⅷ Product
Table 116. GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 117. GreenCross Recent Developments
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Human Coagulation Factor Ⅷ Product
Table 121. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2018-2024) & (US$ Million)
Table 122. Pfizer Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Human Coagulation Factor Ⅷ Market Share by Type: 2022 VS 2029
Figure 3. Recombinant Factor VIII Features
Figure 4. Human Factor VIII Features
Figure 5. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Human Coagulation Factor Ⅷ Market Share by Application: 2022 VS 2029
Figure 7. Hemophilia A Case Studies
Figure 8. Relvent Bleeding Diseases Case Studies
Figure 9. Human Coagulation Factor Ⅷ Report Years Considered
Figure 10. Global Human Coagulation Factor Ⅷ Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Human Coagulation Factor Ⅷ Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Coagulation Factor Ⅷ Market Share by Region: 2022 VS 2029
Figure 13. Global Human Coagulation Factor Ⅷ Market Share by Players in 2022
Figure 14. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Human Coagulation Factor Ⅷ Revenue in 2022
Figure 16. North America Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
Figure 18. North America Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
Figure 19. North America Human Coagulation Factor Ⅷ Market Share by Country (2018-2029)
Figure 20. United States Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Human Coagulation Factor Ⅷ Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
Figure 24. Europe Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
Figure 25. Europe Human Coagulation Factor Ⅷ Market Share by Country (2018-2029)
Figure 26. Germany Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Human Coagulation Factor Ⅷ Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
Figure 34. China Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
Figure 35. Asia Human Coagulation Factor Ⅷ Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
Figure 37. Asia Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
Figure 38. Asia Human Coagulation Factor Ⅷ Market Share by Region (2018-2029)
Figure 39. Japan Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Human Coagulation Factor Ⅷ Market Share by Country (2018-2029)
Figure 49. Brazil Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Human Coagulation Factor Ⅷ Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Bayer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 56. CSL Behring Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 57. Baxter Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 58. Grifols Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 59. Octapharma Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 60. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 61. Taibang Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 62. Shanghai Laishi Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 63. Hualan Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 64. Guangdong Shuanglin Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 65. GreenCross Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 66. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries